My awesome and deserving daughter Julie, a short track speedskater for Team USA, is nominated for the AAU Sullivan Award. Please vote to help her!!. Easy! Share with friends! You can vote daily until Tuesday. I appreciate it. bit.ly/aausullivan_jl…

The one type of breast cancer whose recurrence is impossible stop! Cannot keep this journal from coming.

Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML | Blood | American Society of Hematology ashpublications.org/blood/article/…

In February, U.S. speed skaters won a total of 27 medals, 11 of which were 🥇👏

Are you attending #AACRprecmed25? Check out this Spotlight by Anthony Letai: brnw.ch/21wRfZn Anthony Letai MD PhD

A new preprint from our group about the importance of the SARS-CoV-2 spike furin cleavage site (FCS) for pathogenesis and possibly transmission. tinyurl.com/2dya48ky

Read the precision oncology article collection. brnw.ch/21wRhBc #AACRprecmed25

Today at #AACRprecmed25, Paul Boutros will speak on the evolutionary origins of cancer lethality. Read his work recently published in Cancer Discovery: brnw.ch/21wRhOV

Great talks next week, please join us ! BIDMC Cancer Center

No other class of anticancer drug comes close to the number of cures that can be attributed to chemotherapy. Yet, our understanding of how it truly works is extremely limited. This perspective on the topic is a must read. Including for ADC enthusiasts. nature.com/articles/s4156…

Why is the UPR activated upon glucose deprivation? a reviewer asked. Why is IRE1 activated when glucose is low? a committee member for Mabel Cruz's PhD asked. Mabel was surprised about the questions (is this not widely known?) So we wrote a review about it with Eric Chevet.

The BCL-2 inhibitor venetoclax, given in combination with a hypomethylating agent, has transformed the management of newly diagnosed AML in patients who are older or are otherwise not fit for IC. ow.ly/WM4J50VHuAY #clinicaltrialsandobservations

Very excited about the first Irish Multiple Myeloma meeting being held this September. Mark the calendar, it should be great. Organised by Siobhan Glavey Physiology RCSI Irish Multiple Myeloma Society

Strong bipartisan advocacy for cancer research funding expressed at the 2025 AACI/AACR Hill Day Reception, Rayburn House Office Building. NIH National Cancer Institute #AACRontheHill #FundNIH #AACIontheHill AACR Association of American Cancer Institutes

Fantastic talk by The Fuchs lab on the highly anticipated work on inflammatory memory with aging… congratulations to Raj Sajjath, Christopher Cowley, PhD, Luis F. Soto-Ugaldi et al #aging #cshl

Are you ready for it? VEN-HMA for younger patients with AML >>> Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML doi.org/10.1182/blood.… #leusm #AML

The most practice changing trial from #ASCO25 is now live on NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.

CAR T-immunotherapy has made big strides in blood cancer treatment, but it still has room to grow. 🧬 Anthony Letai MD PhD's LLS-supported research is focused on improving the staying power of CAR T-cells. More on this promising research 👉 bit.ly/45ZHal7

Herculean effort from Lorenzo Galluzzi and team to COMPREHENSIVELY review how #caspases promote or suppress inflammatory signaling. Recent discoveries show that caspase signaling, and ultimately organismal responses, are nuanced and context-dependent. #apoptosis #inflammation

Huge congratulations to Andy on the publication of his PhD work! This was a massive team effort, thanks to the lab for helping out & collaborators: CatríonaMDowling PhD SchoenLab Emma Kerr Marie McIlroy Read it here: rdcu.be/eyagL 🙏 Research Ireland For Funding.